Rodolphe Clerval

Rodolphe Clerval

Company: Coave Therapeutics

Job title: CEO

Seminars:

AAV-ligand Conjugates, a New Capsid Platform For Improved Gene Therapy Delivery 11:30 am

AAV capsids from 1st and last generations limitations (efficiency and safety) are related to the nature of the capsid composition Chemical conjugation of AAV capsid alter dramatically the biology of AAV leading to improve bio distribution, transduction and immunological profile Chemical conjugation of AAV is a versatile and scalable new capsid technologyRead more

day: Track A - Day 1 AM

OUR CONTACT DETAILS

T: (+1) 617 455 4188
E: info@hansonwade.com

ABOUT US

Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You’ll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about Careers

LOCATION

Returning July 2023

SEARCH

ORGANISED BY

Terms & Conditions

Privacy Policy

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.